Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial

MN Kosiborod, PS Jhund, KF Docherty, M Diez… - Circulation, 2020 - Am Heart Assoc
Background: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

[PDF][PDF] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

MN Kosiborod, PS Jhund - Circulation, 2020 - ppm.umw.edu.pl
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

[HTML][HTML] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF …

MN Kosiborod, PS Jhund, KF Docherty, M Diez… - Circulation, 2020 - ncbi.nlm.nih.gov
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

MN Kosiborod, PS Jhund - Circulation, 2020 - Am Heart Assoc
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

MN Kosiborod, PS Jhund, KF Docherty, M Diez… - Circulation, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Goals of management in
patients with heart failure and reduced ejection fraction include reducing death and …

[PDF][PDF] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

MN Kosiborod, PS Jhund - Circulation, 2020 - scholar.archive.org
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

[引用][C] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF …

MN Kosiborod, PS Jhund, KF Docherty, M Diez… - Circulation, 2020 - repositorio.usp.br
ReP USP - Detalhe do registro: Effects of Dapagliflozin on Symptoms, Function, and Quality
of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF …

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial

MN Kosiborod, PS Jhund, KF Docherty, M Diez… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial

MN KOSIBOROD, PS JHUND, KF DOCHERTY… - …, 2020 - observatorio.fm.usp.br
Background: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …

[PDF][PDF] Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

MN Kosiborod, PS Jhund - Circulation, 2020 - core.ac.uk
BACKGROUND: Goals of management in patients with heart failure and reduced ejection
fraction include reducing death and hospitalizations, and improving health status …